0.82
-0.0409(-4.77%)
Currency In USD
| Previous Close | 0.86 |
| Open | 0.85 |
| Day High | 0.85 |
| Day Low | 0.8 |
| 52-Week High | 11.2 |
| 52-Week Low | 0.8 |
| Volume | 101,517 |
| Average Volume | 502,304 |
| Market Cap | 4.14M |
| PE | -0.15 |
| EPS | -5.56 |
| Moving Average 50 Days | 1.56 |
| Moving Average 200 Days | 3.07 |
| Change | -0.04 |
If you invested $1000 in Beyond Air, Inc. (XAIR) since IPO date, it would be worth $13.84 as of December 25, 2025 at a share price of $0.817. Whereas If you bought $1000 worth of Beyond Air, Inc. (XAIR) shares 5 years ago, it would be worth $7.87 as of December 25, 2025 at a share price of $0.817.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
GlobeNewswire Inc.
Dec 17, 2025 12:30 PM GMT
Distribution network coverage expanded to a total of 39 countriesGARDEN CITY, N.Y., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company f
Beyond Air® Announces Transition of Chief Financial Officer
GlobeNewswire Inc.
Nov 26, 2025 9:30 PM GMT
Launched search for permanent successorGARDEN CITY, N.Y., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the p
Beyond Air® Secures Up to $32 Million to Accelerate Growth
GlobeNewswire Inc.
Nov 05, 2025 1:00 PM GMT
Enters agreements for a $12 million promissory note and a $20 million equity line of credit with Streeterville Capital Proforma cash, cash equivalents, restricted cash and marketable securities of $22.9 million as of September 30, 2025, including $12